Transition Care Program for Type 1 Diabetes
(SHIFT2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help adolescents and young adults with type 1 diabetes transition from pediatric to adult medical care. It tests a transition preparation program that includes coaching sessions and supportive messages to encourage self-management of diabetes. Participants will be divided into two groups: one receiving the full program with sessions and messages, and another receiving regular medical visits and monthly educational materials. Suitable candidates have had type 1 diabetes for at least a year, are patients at the Children's Hospital of Richmond, speak English, and have a caregiver willing to participate.
As an unphased trial, this study offers a unique opportunity to enhance the transition to adult care with personalized support.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this transition preparation program is safe for adolescents and young adults with type 1 diabetes?
Research shows that programs designed to help young adults with type 1 diabetes transition to adult care are safe and well-received. Studies have found that these programs assist young people in moving to adult healthcare smoothly. Participants reported no serious issues during or after these programs. The main goal is to help young adults manage their diabetes more effectively as they age.
In other studies, young adults and their parents participated in a 6-month program to prepare for the switch to adult healthcare. This program succeeded without causing any negative effects. Participants found it useful for learning to manage their condition independently.
Overall, the transition preparation program is a proven safe way to support young people with type 1 diabetes.12345Why are researchers excited about this trial?
Researchers are excited about this Transition Care Program for Type 1 Diabetes because it focuses on empowering young people during a crucial transition period. Unlike standard care, which typically involves regular medical visits and general education, this program offers a personalized approach with sessions led by a transition coach, encouraging self-management behaviors through bi-weekly messages. Additionally, it involves parents by providing them with resources to support their child's transition, which isn't a common feature in existing treatments. This holistic and supportive approach aims to smooth the transition from pediatric to adult care, potentially improving long-term diabetes management for adolescents and young adults.
What evidence suggests that this transition preparation program is effective for adolescents and young adults with type 1 diabetes?
Research has shown that a transition preparation program can help teenagers and young adults with type 1 diabetes manage their condition better as they move from child to adult healthcare. In this trial, participants in Group A will engage in the SHIFT2 program, which aims to improve outcomes by teaching self-care skills and offering support during this important time. Studies have found that many young people with type 1 diabetes struggle to maintain their blood sugar levels within the target range during this transition. Programs like SHIFT have been linked to fewer breaks in care and fewer diabetes-related problems. Meanwhile, participants in Group B will receive educational materials as part of routine medical visits. Overall, these programs aim to make the transition to adult care smoother and safer for young people with type 1 diabetes.23678
Who Is on the Research Team?
Laura Caccavale
Principal Investigator
Virginia Commonwealth University
Are You a Good Fit for This Trial?
This trial is for English-speaking adolescents and young adults aged 16-22 with Type 1 Diabetes, who have been patients at the Children's Hospital of Richmond for over a year. They must have a caregiver over 18 willing to participate. Excluded are those with psychiatric disorders, non-Type 1 diabetes, recent severe mental health issues, current pregnancy or breastfeeding, or involvement in conflicting studies.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a 6-month transition preparation program with monthly sessions and bi-weekly messages for diabetes management
Follow-up
Participants are monitored for changes in diabetes distress, support, adherence, self-efficacy, quality of life, and HbA1C
What Are the Treatments Tested in This Trial?
Interventions
- Educational materials
- Transition preparation program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Virginia Commonwealth University
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator